#oncotwitter
LightNews LightNews
katesears.bsky.social
🔬 Conclusion: Perioperative Durvalumab in MIBC = clinically effective + socioeconomically justified

#BladderCancer #GUcancer #OncoTwitter #Immunotherapy #HealthEconomics #Medicalwatch 🚀

www.ejcancer.com/article/S095...
www.ejcancer.com
September 9, 2025 at 4:33 PM
katesears.bsky.social
✅ Barriers: resource gaps, training, access in LMICs

➡️ Clinical practice impact: GA should be mandatory in global oncology to optimize outcomes for older adults.

#GeriatricOncology #ASCO #OncoTwitter #Medicalwatch #CancerCare #GlobalOncology
ascopubs.org/doi/10.1200/...
Geriatric Assessment: ASCO Global Guideline | JCO Global Oncology
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO Guidelines Methodology Manual, ASCO Guidelines follow ...
ascopubs.org
September 5, 2025 at 8:05 PM
katesears.bsky.social
💡 Clinical Tip: FGFR1 amplification defines a high-risk CRC subset. IRS-based IHC scoring may serve as practical biomarker to identify candidates for novel FGFR1-targeted strategies.

#ColorectalCancer #FGFR1 #Biomarkers #PrecisionOncology #OncoTwitter #Medicalwatch
www.esmoopen.com/article/S205...
FGFR1-amplified colorectal cancer: a distinct prognostic subtype identified through integrated genomic and immunohistochemical profiling
Fibroblast growth factor receptor (FGFR) alterations are established therapeutic targets in cholangiocarcinoma and urothelial carcinoma but remain understudied in colorectal cancer (CRC). This study i...
www.esmoopen.com
September 3, 2025 at 5:47 PM
katesears.bsky.social
✅ 5-yr survival overall: 98%, but only 36–43% in metastatic stage

#MedicalWatchPapers #OncoTwitter #ProstateCancer #CancerStats

💡 Clinical tip: Early detection + equitable access remain key. Discuss PSA screening with men 55–69y, start earlier for Black men & those with strong family history.
September 2, 2025 at 4:29 PM
katesears.bsky.social
✅ Systemic Tx: Peri-op #IO & targeted adjuvant (osimertinib, alectinib) improve DFS/OS
✅ Stage III: CRT ➕ durvalumab (WT) / osimertinib (EGFR+) = new SoC

#GlobalUpdate #MedicalwatchPapers #LungCancer #OncoTwitter #ESMO25
www.annalsofoncology.org/article/S092...
Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Surgical diagnosis should be limited to cases with small high-risk nodules, including those with negative positron emission tomography (PET)–CT findings and/or inability to obtain tissue by less invas...
www.annalsofoncology.org
August 29, 2025 at 2:49 PM
katesears.bsky.social
#GeriOncology #ASCOGuideline #GlobalOnc #CancerCare #OncoTwitter #Medicalwatch
ascopubs.org/doi/pdf/10.1...
Geriatric Assessment: ASCO Global Guideline | JCO Global Oncology
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO G...
ascopubs.org
August 28, 2025 at 2:33 PM
katesears.bsky.social
✅ Highlights the urgent need for equity & global trial harmonization.

❓ Question to think: Should trial standards always reflect the best global care — or adapt to local realities?

#OncoEthics #GlobalOncology #ClinicalTrials #OncoTwitter #Medicalwatch
bmjoncology.bmj.com/content/4/1/...
Inferior control arms in oncology trials in LMICs: contextualised or compromised?
In recent years, cancer drug randomised controlled trials (RCTs) have been criticised for employing a control arm treatment that is inferior or suboptimal to the existing standard of care.1 2 Using an...
bmjoncology.bmj.com
August 27, 2025 at 2:43 PM
katesears.bsky.social
💡 Clinical Tip: In MBC (esp. HER2+ & TNBC), discuss brain metastasis risk proactively — patient-centered dialogue is key while awaiting trial evidence.
#BreastCancer #BrainMets #MetastaticBC #OncoTwitter #MedicalWatch
August 26, 2025 at 2:44 PM
katesears.bsky.social
🔮 Future: digital twins, living evidence pipelines & multimodal decision-support at point of care
#AI #Oncology #CancerCare #DigitalHealth #OncoTwitter #MedicalWatch
acsjournals.onlinelibrary.wiley.com/doi/10.1002/...
Artificial intelligence across the cancer care continuum
This review highlights the expanding role of artificial intelligence across the cancer care continuum, from risk prediction to end-of-life care. It emphasizes both the promise of artificial intellige...
acsjournals.onlinelibrary.wiley.com
August 25, 2025 at 2:57 PM
medicalwatch.bsky.social
#BreastCancer #HER2 #T-DXd #SacituzumabGovitecan #OncoTwitter #MedicalWatch #MBC
academic.oup.com/jnci/advance...
Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer
AbstractBackground. Most patients with metastatic breast cancer (MBC) are eligible for treatment with trastuzumab deruxtecan (T-DXd). No data are available
academic.oup.com
August 15, 2025 at 4:36 PM
pums-poznan.bsky.social
"A new machine learning tool developed by scientists at #PUMS and the University of São Paulo offers a new approach by using protein expression to predict the aggressiveness of tumours"
www.drugtargetreview.com/news/178935/...
#AI #oncology #oncotwitter #diagnostics #PROTsi
July 25, 2025 at 1:55 PM
schettinif87.bsky.social
Useful updated treatment algorithms for HR+ #breastcancer from @ilanaschlam.bsky.social

We had them on OncoTwitter, now we have it on #OncSky / #oncosky (still figuring out the best hashtag @erikahamilton9.bsky.social 😁)
November 20, 2024 at 6:48 AM
sasankaatapattu.bsky.social
Remote monitoring + PROs in oncology reduced ED visits & improved symptom management with 80% adherence to weekly/monthly questionnaires. Digital health tools showing real clinical impact. buff.ly/4f6j9us #OncoTwitter #SupportiveCare #DigitalHealth
Digital Health Applications in Oncology: An Opportunity to Seize
Digital health advances have transformed many clinical areas including psychiatric and cardiovascular care. However, digital health innovation is relatively nascent in cancer care, which represents th...
buff.ly
November 19, 2024 at 9:22 PM